Asia Pacific Virus-like Particles Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Hepatitis, Cancer/HPV, and Gaucher disease), Source (Yeast, Insect Cell, Plant, and Others), and Application (Vaccines and Therapeutics)

TIPRE00026817 | Pages: 125 | Pharmaceuticals | Jan 2022 | Type: Regional | Status: Published

The virus-like particles market in Asia Pacific is expected to grow from US$ 1,018.83 million in 2021 to US$ 1,769.02 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.

Various players in the healthcare market and research organizations are actively involved in product innovations and developments. The use of virus-like particles is an emerging approach used in the biopharmaceuticals industry. As virus-like particles lack the viral content, they are easier to handle than the actual viral components. The VLPs can be used for aiding drug delivery, imaging, immunotherapy, and theragnostic. For instance, as per a study published in the NCBI in June 2020, VLP can be used in the form of nanoparticles in applications such as photothermal therapy, PET and CT imaging, MRI contrast agent carriers, optical imaging, inflammatory and autoimmune disease vaccines, cancer immunotherapy, and small molecule drug delivery (in cancer therapy). Thus, such potential applications of VLPs are expected to provide growth opportunities to market players during the forecast period.

 

According to the International Monetary Fund (IMF) report, growth in Asia Pacific was expected to remain stall at zero percent in 2020. This was the worst growth performance in almost 60 years involving the Global Financial Crisis (4.7%) and the Asian Financial Crisis (1.3%). Downward revisions were substantial that ranging from 3.5% in the case of Korea but have appeared to manage with the slow spread of coronavirus due to minimized prolonged production shutdowns accounting for 9% in Australia, New Zealand, and Thailand. These countries were a large hit due to the worldwide tourism shutdown and, in the case of Australia, by lower commodity prices. The Asia Pacific, where COVID-19 vaccines are currently being developed, includes South Korea, China, Japan, Thailand, and Vietnam. Among these, China has 15 vaccines, India and South Korea possess three vaccines, Japan has two vaccines, and Thailand and Vietnam have one vaccine. Among these vaccines it include ten inactivated vaccines, six protein subunit vaccines, seven viral vector vaccines, and six nucleic acid vaccine. Furthermore, promoting a safe, equitable, and effective vaccine is a top priority in the Asia Pacific region. As per the report by the Asian Development Bank, in December 2020, The Asian Development Bank (ADB) has launched a US$9 Billion vaccine initiative with the Asia Pacific Vaccine Access Facility (APVAX) that will offer rapid and equitable support to the developing member countries (DMCs) to procure and deliver effective and safe COVID-19 vaccine. Through vaccination, it can break the chain of virus transmission, saving lives, and mitigating the negative impact of the pandemic.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific virus-like particles market. The Asia Pacific virus-like particles market is expected to grow at a good CAGR during the forecast period.

 

  Asia Pacific Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)  

Get more information on this report :

 

Asia Pacific Virus-like Particles Market Segmentation

 

Asia Pacific Virus-like Particles Market – By Product type

  • Hepatitis
  • Cancer/HPV
  • Gaucher Disease

Asia Pacific Virus-like Particles Market – By Source

  • Yeast
  • Insect Cell
  • Plant
  • Others

Asia Pacific Virus-like Particles Market – By Application

  • Vaccines
  • Therapeutics

Asia Pacific Virus-like Particles Market – By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific     

Asia Pacific Virus-like Particles Market – Companies Mentioned

  • Merck & Co., Inc.                                                       
  • GlaxoSmithKline plc.
  • Pfizer Inc.                                                                     
  • Sanofi                                                                          
  • Serum Institute of India Pvt. Ltd.                            
  • BHARAT BIOTECH                                                      
  • LG Chem                                                                    
  • Wantai BioPharm

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Virus-like Particles Market – By Product Type

1.3.2        Asia Pacific Virus-like Particles Market – By Source

1.3.3        Asia Pacific Virus-like Particles Market – By Application

1.3.4        Asia Pacific Virus-like Particles Market – By Country

2.           Asia Pacific Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Prevalence of Infectious Viral Diseases

5.1.2        Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Reach of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Growing Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Steady Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Asia Pacific Virus-like Particles Market Analysis

6.1         Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis

7.           Asia Pacific Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

10.1.1.1.4       Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.1.5       Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.2.5       China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5       South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4       Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5       Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4       Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Asia Pacific Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Wantai BioPharm

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Serum Institute of India Pvt. Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BHARAT BIOTECH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      LG Chem

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 3.             Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 4.             Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6.             China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 7.             China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 9.             India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13.          South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 15.          Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 16.          Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20.          Organic Developments Done by Companies

Table 21.          Inorganic Developments Done by Companies

Table 22.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           Asia Pacific Virus-like particles Market Segmentation

Figure 2.           Asia Pacific Virus-like particles Market Segmentation, By Country

Figure 3.           Asia Pacific Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market

Figure 5.           India to Show Significant Growth during Forecast Period

Figure 6.           Asia Pacific Virus-like Particles Market, Industry Landscape

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Asia Pacific Virus-like Particles Market Overview, by Country (2021)

Figure 23.        Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem                                                                     
  8. Wantai BioPharm
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000